USPTO serial 87455742
FUCO-N-TETRAOSE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GULIANO, ROBERT N
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FUCO-N-TETRAOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hørsholm, DK
Hørsholm, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephanie L. Crigler
Stephanie L. Crigler Dinsmore & Shohl LLP227 W. Monroe Street, Suite 3850Chicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biologic preparations and chemical additives for use in industry and for manufacturing use in the food industry; chemical and biologic preparations and chemical additives for use in the manufacture of pharmaceuticals, nutraceuticals, dietary supplements, infant formula, foodstuffs and animal foods; human milk oligosaccharide (HMO) preparations for use in industry and as raw material in the manufacture of other goods and other than for medical use; human milk oligosaccharide (HMO) additives for use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds used as raw materials in the food industry; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for scientific use other than for medical or veterinary use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for industrial use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; chemicals for use as an additive in the manufacture of dietary supplements and infant formula | ACTIVE | — |
| 005 | Dietary and nutritional supplements; vitamins and dietary food supplements for animals; food for babies; vitamins and vitamin preparations; dietetic food and substances, namely, human milk oligosaccharide adapted for medical or veterinary use in food for babies and infant formula; dietary supplements for humans and animals; medicated food additives in the nature of dietary supplements containing human milk oligosaccharide for humans and for animals; medicated preparations for use as additives for food for human or animal consumption, namely, human milk oligosaccharide for medical or veterinary purposes and vitamin preparations for use as a supplement for dietary supplements and infant formula; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humans, including for infants, and for animals; mineral food supplements; colostrum dietary supplements; dietary supplemental drinks and nutritionally fortified beverages for medical purposes; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds for medical purposes; human milk oligosaccharide additives being dietary and nutritional supplements for use as supplements in connection with pharmaceuticals, nutraceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 14, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 14, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 12, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 22, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 24, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 22, 2017 | NWAP | NEW APPLICATION ENTERED | — |